Aquarius Biotechnologies
Stage
Unattributed | AliveTotal Raised
$320KLast Raised
$320K | 9 yrs agoAbout Aquarius Biotechnologies
Aquarius Biotechnologies is founded on a drug delivery platform called "cochleates." When applied to existing drugs, cochleates have demonstrated the ability to address both of the issues highlighted above by: 1) creating oral drug alternatives with non-inferior efficacy for drugs that are currently only available via IV and 2) reducing the toxicity of drugs.
Missing: Aquarius Biotechnologies's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Aquarius Biotechnologies's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Aquarius Biotechnologies Patents
Aquarius Biotechnologies has filed 2 patents.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
1/29/2015 | 6/21/2016 | Alkene derivatives, Calcium channel blockers, Membrane biology, Serotonin receptor agonists, Piperidines | Grant |
Application Date | 1/29/2015 |
---|---|
Grant Date | 6/21/2016 |
Title | |
Related Topics | Alkene derivatives, Calcium channel blockers, Membrane biology, Serotonin receptor agonists, Piperidines |
Status | Grant |
Aquarius Biotechnologies Frequently Asked Questions (FAQ)
Where is Aquarius Biotechnologies's headquarters?
Aquarius Biotechnologies's headquarters is located at 2037 W Carroll Avenue, Chicago.
What is Aquarius Biotechnologies's latest funding round?
Aquarius Biotechnologies's latest funding round is Unattributed.
How much did Aquarius Biotechnologies raise?
Aquarius Biotechnologies raised a total of $320K.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.